BNET Industries
Last Fiscal Year Sales:$250.5K
- Private
- US
Dow Jones Description
High quality sampling supplies, most competitive prices, exceptional service. We are striving to become the most reliable source for the environmental and geotechnical industries.
Owner
Larry ZhangNumber of Employees 7
Contact Information
14146 Firestone Blvd
Santa Fe Springs, California 90670
1 562 802 7010
Peer Companies
NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414
News & Analysis
Filter by
cel-sci corp. - All News and Analysis
Cel-Sci: Good News Could Lead to Long-Term Growth
VFC submits: As shares of Cel-Sci Corp. CVM have traded to the upside of late, the company is set to gain more exposure when it presents at the "7th Annual Vaccines: All Things Considered Conference" in Washington, DC on Tuesday afternoon. While I don't expect the Cel-Sci stock to...
Cel-Sci, Johns Hopkins Move Forward With LEAPS
VFC submits: Shortly after the market open on Friday, Cel-Sci Corp. CVM issued a press release declaring that the company will commence a Clinical Study measuring the effectiveness of the company's LEAPS technology in the treatment of H1N1-hospitalized patients. According to the press release, blood will be drawn from...
Cel Sci's Targets Stay on Track
VFC submits: Last week I had the opportunity to visit Cel Sci's CVM new, state of the art Multikine production facility near Baltimore, MD. During the visit, I was given a tour of the interior by Dr. Eyal Talor and Mr. W. Brooke Jones of Cel Sci Corp. Upon...
Cel-Sci: Things Are Just Getting Started
VFC submits: CVM: Shares of Cel Sci traded with continued volatility on Monday, after the company announced positive results for CEL-2000 (based on the company's LEAPS technology) in the treatment of Rheumatoid arthritis at the American College of Rheumatology Conference in Philadelphia on Sunday. It was also noted...
Cel-Sci: Why I'm Buying if the Price Dips
VFC submits: In "Readers Respond" I do my best to answer readers' questions, but keep in mind that these questions are my opinions and personal speculation that I have based on my own research and due diligence (DD). I don't invent the facts that are based in publicly available...
Cel Sci: Job Listings Are a Good Sign
VFC submits: What's left to say about Cel Sci Corp. CVM? That company and its stock have received a heck of a lot of press over the past couple of weeks and I maintain my opinion that - in my opinion - the stock will pay off based on...
Remaining Grounded Through the Unethical Attacks on Cel Sci
VFC submits: [Update below] Shares of Cel Sci Corp CVM were on the rebound during early trading on Wednesday after the effects of some unfounded attacks on the company by Adam Feuerstein and The Street.com look to have finally wore off. by VFC's Stock House
Investors Should Ignore the Hoopla Around Cel Sci
VFC submits: Shares of Cel Sci CVM traded down during pre-market trading on Tuesday after The Street.com published yet another article bashing the company and the potential of its pipeline. Undoubtedly some shareholders are going to be shaken out of the stock by the antics of Feuerstein, but I...
Cel-Sci May Be in for a Bumpy Ride This Week
VFC submits: It looks like the writing staff at BioMedReports.com, most notably M. E. Garza, must be getting under Adam Feuerstein's skin because he's decided to enact a personal vendetta with the website. The thing is, it makes Adam and his puppetmasters at the The Street.com looks pretty bad...
Antigenics, Cel-Sci Could Both Become Billion Dollar Companies
VFC submits: Here's a rundown of how I personally apply timeframes to my short, mid and long term picks.Quite simply, I consider a short term pick to be any stock that I feel will pay off fairly significantly within six months; mid term is six months to two years...
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Larry Zhang | Owner |
| Organization | Position | Status |
|---|---|---|
| Cel Scientific Corporation | Owner | Current |
Industry Transcripts by Seeking Alpha
-
Alexza Pharmaceuticals, Inc., Q3 2009 Earnings Call Transcript
on Nov 09, 2009about ALXA
-
Salix Pharmaceuticals Ltd Q3 2009 Earnings Call Transcript
on Nov 09, 2009about SLXP
-
ACADIA Pharmaceuticals, Inc. Q3 2009 Earnings Conference Call
on Nov 09, 2009about ACAD
-
XOMA Ltd. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about XOMA
-
Halozyme Therapeutics, Inc. Q3 2009 Earnings Call Transcript
on Nov 06, 2009about HALO
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- The 10 Weirdest Drug Stories of the Month 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes

